ABCC5 and hepatocellular carcinoma: ZDV suppressed ABCC5 expression (~50%), activated p53 signaling (p53↑2.0-fold), and inhibited HCC migration and proliferation more effectively than the ABCC5-specific inhibitor MK-571.